Extended surveillance of gonorrhoea in Scotland 2003

Int J STD AIDS. 2006 Oct;17(10):687-92. doi: 10.1258/095646206780070965.

Abstract

In 2003, a national surveillance of demographic, behavioural, clinical and laboratory data on gonorrhoea at genitourinary (GU) medicine clinics in Scotland was undertaken. The data-set represented 77% of all gonorrhoea cases. Findings were compared with data reported from England and Wales. Young women (16-19 years) and young men (20-24. years) represented the greatest proportion of heterosexual infections in Scotland (36 and 30%, respectively) and in England and Wales (37 and 32%, respectively). In Scotland (relative to England and Wales), men who have sex with men (MSM) accounted for more of the total gonorrhoea; there were more heterosexuals aged 45+ years; fewer belonged to ethnic minorities; fewer had had gonorrhoea previously; more heterosexual men had a sexual partner abroad; ciprofloxacin resistance was higher. During the year, first-line therapy changed from ciprofloxacin to a third-generation cephalosporin. Extended surveillance for gonorrhoea is vital in guiding appropriately targeted interventions as the epidemiology of gonorrhoea may differ in neighbouring countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Ambulatory Care Facilities
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / pharmacology
  • Cephalosporins / therapeutic use
  • Ciprofloxacin / pharmacology
  • Ciprofloxacin / therapeutic use
  • Drug Resistance, Bacterial
  • Female
  • Gonorrhea / drug therapy
  • Gonorrhea / epidemiology*
  • Hospitals
  • Humans
  • Male
  • Middle Aged
  • Neisseria gonorrhoeae / drug effects
  • Population Surveillance*
  • Primary Health Care
  • Scotland / epidemiology
  • Sexual Behavior
  • Surveys and Questionnaires*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Cephalosporins
  • Ciprofloxacin